[Federal Register Volume 64, Number 183 (Wednesday, September 22, 1999)]
[Notices]
[Pages 51327-51328]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-24597]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Psychopharmacologic Drugs Advisory Committee; Amendment of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an 
amendment to the notice of meeting of the Psychopharmacologic Drugs 
Advisory Committee. This meeting was announced in the Federal Register 
of August 26, 1999 (64 FR 46687). The

[[Page 51328]]

amendment is being made to cancel the entire session on October 7, 
1999. This meeting will be open to the public. There are no other 
changes.

FOR FURTHER INFORMATION CONTACT: Sandra L. Titus, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093) 
Rockville, MD 20857, 301-827-7001, or e-mail ``[email protected]'', 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area) code 12544. Please call the 
Information Line for up-to-date information on this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of August 26, 1999 
(64 FR 46687), FDA announced that a meeting of the Psychopharmacologic 
Drugs Advisory Committee would be held on October 7 and 8, 1999. On 
page 46687, beginning in the first column, the Date and Time, Agenda, 
and Procedure portions of this meeting are amended to read as follows:
    Date and Time: The meeting will be held October 8, 1999, 8 a.m. to 
4:30 p.m.
    Agenda: On October 8, 1999, the committee will consider the safety 
and efficacy of new drug application 19-839/S-026, Zoloft, 
(sertraline hydrochloride, Pfizer Pharmaceuticals) proposed to treat 
posttraumatic stress disorder.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by October 1, 
1999. Oral presentations from the public will be scheduled between 
approximately 1 p.m. and 2 p.m. Time allotted for each presentation may 
be limited. Those desiring to make formal oral presentations should 
notify the contact person before October 1, 1999, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.

    Dated: September 13, 1999.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 99-24597 Filed 9-21-99; 8:45 am]
BILLING CODE 4160-01-F